Is Cellyan Biotechnology Co., Ltd (HKPD) Halal?
Shariah Screening — 5 Standards
Based on financial data from March 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 33.2% / 30% | 42.0% / 30% | 65.9% / 30% | 0.01% / 5% | ✗ NOT HALAL |
| DJIM | 33.2% / 33% | 42.0% / 33% | 65.9% / 33% | 0.01% / 5% | ✗ NOT HALAL |
| MSCI | 25.2% / 33% | 31.9% / 33% | 50.0% / 33% | 0.01% / 5% | ✗ NOT HALAL |
| S&P | 33.2% / 33% | 42.0% / 33% | 65.9% / 33% | 0.01% / 5% | ✗ NOT HALAL |
| FTSE | 25.2% / 33% | 31.9% / 33% | 50.0% / 50% | 0.01% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 8.8% | |
| Operating Margin | 3.0% | |
| Net Margin | -4.3% | |
| Return on Equity (ROE) | -13.4% | |
| Return on Assets (ROA) | -3.9% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $569,214 |
| Free Cash Flow | $414,226 |
| Total Debt | $2M |
| Debt-to-Equity | 44.2 |
| Current Ratio | 2.9 |
| Total Assets | $9M |
Price & Trading
| Last Close | $0.66 |
| 50-Day MA | $0.72 |
| 200-Day MA | $1.07 |
| Avg Volume | 39K |
|
52-Week Range
$0.58
| |
About Cellyan Biotechnology Co., Ltd (HKPD)
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Cellyan Biotechnology Co., Ltd (HKPD) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Cellyan Biotechnology Co., Ltd is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Cellyan Biotechnology Co., Ltd's debt ratio?
Cellyan Biotechnology Co., Ltd's debt ratio is 33.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 25.2%.
What are Cellyan Biotechnology Co., Ltd's key financial metrics?
Cellyan Biotechnology Co., Ltd has a market capitalization of $7M, and revenue of $20M. The company maintains a gross margin of 8.8% and a net margin of -4.3%. Return on equity stands at -13.4%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.